Filters

Cetrorelix manufacturers

Filters

Filters

Filters , active

Country of origin : China
None products found

cetrorelix

Injection 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #29288

This hi-tech enterprise specializes in the research and manufacturing of diverse peptide products. Founded in 1998, it has become one of the leading peptide pharmaceutical companies globally, offering a full range of services including finished dosage products, APIs, and CRO/CMO services. Their finished dosage products are primarily sold domestically, while APIs have international distribution. The company operates a GMP-certified manufacturing facility exceeding 1500 sq. m., regularly inspected by local and international authorities. They focus on several key therapy areas, employing various principal dosage forms, including peptide-based formulations.

Manufacturer usually replies in 7 days

cetrorelix

Injection 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
PICS
Manufacturer #23879
China-based pharmaceutical company specializing in Rx peptide active ingredients and peptide-based formulations. Products target endocrine, metabolic, and oncology therapy areas and are supplied to domestic and international customers across multiple continents. Facilities hold GMP approvals from several international regulatory authorities.

Manufacturer usually replies in 18 days

cetrorelix

Powder for solution for injection 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
WHO
Manufacturer #7041

This pioneering genetic-engineering–based pharmaceutical company is known for its advances in child and women’s health, supported by nearly three decades of experience in biopharmaceuticals and innovative drug development. It operates tech-driven R&D platforms with over 80 pipeline projects and more than 120 marketed products. The organization is expanding into additional high-need therapeutic areas, including endocrinology, immunology and oncology, while actively pursuing global innovation and commercial partnerships.

Manufacturer usually replies in 74 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.